Your browser doesn't support javascript.
loading
Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial).
Kähler, Katharina C; Hüning, S; Nashan, D; Meiss, F; Rafei-Shamsabadi, D A; Rissmann, H; Colapietro, C; Livingstone, E; Maul, L V; Heppt, M; Hassel, J C; Gutzmer, R; Loquai, C; Heinzerling, L; Sachse, M M; Bohne, A S; Moysig, L; Peters, W; Rusch, J; Blome, C.
Afiliación
  • Kähler KC; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. katharina.kaehler@uksh.de.
  • Hüning S; Department of Dermatology, Dortmund, Germany.
  • Nashan D; Department of Dermatology, Dortmund, Germany.
  • Meiss F; Department of Dermatology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Rafei-Shamsabadi DA; Department of Dermatology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Rissmann H; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
  • Colapietro C; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
  • Livingstone E; Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Maul LV; Department of Dermatology, University Hospital Basel, Basel, Switzerland.
  • Heppt M; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany.
  • Hassel JC; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.
  • Gutzmer R; Department of Dermatology and National Center for Tumor Therapy (NCT), University Hospital Heidelberg, Heidelberg, Germany.
  • Loquai C; Department of Dermatology, Johannes Wesling Medical Center Minden, Ruhr University Bochum Medical School, Bochum, Germany.
  • Heinzerling L; Department of Dermatology, Klinikum Bremen-Ost, Gesundheitnord gGmbH, Bremen, Germany.
  • Sachse MM; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Bohne AS; Department of Dermatology, Bremerhaven, Germany.
  • Moysig L; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
  • Peters W; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
  • Rusch J; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
  • Blome C; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg, Hamburg, Germany.
J Cancer Res Clin Oncol ; 149(13): 11705-11718, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37405475
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Cancer Res Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Cancer Res Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania